Drug and therapeutics bulletin

Keyphrases

Publications

2024

Joanna Girling
Update patients on gonadal and fetal shielding for diagnostic imaging. Drug and therapeutics bulletin (2024)
Benjamin H K Teo, Jonathan T W Au Eong, Kah-Guan Au Eong
Steroid-induced glaucoma: an avoidable cause of irreversible blindness. Drug and therapeutics bulletin (2024)
James A Cave
Medicines and global warming: a complex problem. Drug and therapeutics bulletin (2024)
Ruziana Masiran, Mohamad Nizam Adha Ilias, Putri Binti Yubbu
Methylphenidate-associated chest pain in a child. Drug and therapeutics bulletin (2024)
Alexandra Lewis, Teck K Khong
ADHD medication shortages: more than just a supply issue. Drug and therapeutics bulletin (2024)
Giovanni Cataletti, Fabrizio Santagata, Luca Pastorelli, Pier Maria Battezzati
Severe azathioprine-induced liver injury 22 months after initiation of treatment. Drug and therapeutics bulletin (2024)
David Phizackerley
Protecting consumers: a rich legacy. Drug and therapeutics bulletin (2024)
Indira Acharya, David S Weisman, Lanaya Williams Smith, Lois Johanna Arend
Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis. Drug and therapeutics bulletin (2024)
Chaitanya Bhatt, Zainab Doleeb, Priya Bapat, Christian Pagnoux
Drug-induced haemolysis: another reason to be cautious with nitrofurantoin. Drug and therapeutics bulletin (2024)
Tanya Marie O'Brien
Acute eosinophilic pneumonia-like syndrome post-initiation of vortioxetine. Drug and therapeutics bulletin (2024)
Vivek Vardhan Jasti, Jay Anderson, Ifa Abdujelil
Angioedema without urticaria after recent initiation of celecoxib. Drug and therapeutics bulletin (2024)
Annalise Bellizzi, Elyse Mercieca, Catherine Dimech
Delirium secondary to anticholinergics. Drug and therapeutics bulletin (2024)
Maunoo Lee, Joshua McCarron, Aaron Balinski, Richard Bower
Intravenous acetaminophen associated with acute liver failure. Drug and therapeutics bulletin (2024)
Barbara J Mintzes
Do regulatory safety warnings on medicines miss the mark? Drug and therapeutics bulletin (2024)
David Phizackerley
Supporting the treatment of obesity. Drug and therapeutics bulletin (2024)
Michael Wilcock
Medicines optimisation opportunities: driving change? Drug and therapeutics bulletin (2024)
Roy Taylor
Very low calorie diets and total diet replacement in type 2 diabetes: where are we now? Drug and therapeutics bulletin (2024)
Adrian M J Pokorny
(Un)common sense in oncology. Drug and therapeutics bulletin (2024)
Michael Wilcock
Limiting drugs prescribed in primary care. Drug and therapeutics bulletin (2024)
Mohammed Ahmed, Success Tobore Oyibo, Shailesh Dalvi, Richard Cowell
Hydrocortisone-induced symptomatic sinus bradycardia. Drug and therapeutics bulletin (2024)

volume 62, number 2, 2024

Michael Wilcock
Limiting drugs prescribed in primary care. Drug and therapeutics bulletin 62 (2) (2024)
Alexandra Lewis, Teck K Khong
ADHD medication shortages: more than just a supply issue. Drug and therapeutics bulletin 62 (2) (2024)
Alexandra Lewis, Teck K Khong
ADHD medication shortages: more than just a supply issue. Drug and therapeutics bulletin 62 (2) (2024)
Michael Wilcock
Limiting drugs prescribed in primary care. Drug and therapeutics bulletin 62 (2) (2024)

volume 62, number 3, 2024

volume 62, number 4, 2024

Barbara J Mintzes
Do regulatory safety warnings on medicines miss the mark? Drug and therapeutics bulletin 62 (4) (2024)
Giovanni Cataletti, Fabrizio Santagata, Luca Pastorelli, Pier Maria Battezzati
Severe azathioprine-induced liver injury 22 months after initiation of treatment. Drug and therapeutics bulletin 62 (4) (2024)
Barbara J Mintzes
Do regulatory safety warnings on medicines miss the mark? Drug and therapeutics bulletin 62 (4) (2024)
Giovanni Cataletti, Fabrizio Santagata, Luca Pastorelli, Pier Maria Battezzati
Severe azathioprine-induced liver injury 22 months after initiation of treatment. Drug and therapeutics bulletin 62 (4) (2024)

volume 62, number 5, 2024

James A Cave
Medicines and global warming: a complex problem. Drug and therapeutics bulletin 62 (5) (2024)

volume 62, number 6, 2024

Joanna Girling
Update patients on gonadal and fetal shielding for diagnostic imaging. Drug and therapeutics bulletin 62 (6) (2024)
Mohammed Ahmed, Success Tobore Oyibo, Shailesh Dalvi, Richard Cowell
Hydrocortisone-induced symptomatic sinus bradycardia. Drug and therapeutics bulletin 62 (6) (2024)
Mohammed Ahmed, Success Tobore Oyibo, Shailesh Dalvi, Richard Cowell
Hydrocortisone-induced symptomatic sinus bradycardia. Drug and therapeutics bulletin 62 (6) (2024)

volume 62, number 7, 2024

Jo Congleton
Investing in COPD: biologics or smoking cessation and pulmonary rehabilitation? Drug and therapeutics bulletin 62 (7) (2024)
Anna Moore, Hannah Hylton, Alex Long, Irem Patel
Managing COPD exacerbations in primary care. Drug and therapeutics bulletin 62 (7) (2024)
Ruziana Masiran, Mohamad Nizam Adha Ilias, Putri Binti Yubbu
Methylphenidate-associated chest pain in a child. Drug and therapeutics bulletin 62 (7) (2024)

volume 62, number 8, 2024

David Branford, Anne Webster, David Gill, Teresa Randon, Kirsten Peebles
Challenging use of psychotropic medication in young people. Drug and therapeutics bulletin 62 (8) (2024)
Maunoo Lee, Joshua McCarron, Aaron Balinski, Richard Bower
Intravenous acetaminophen associated with acute liver failure. Drug and therapeutics bulletin 62 (8) (2024)

volume 62, number 1, 2023

Miriam Santer, Esther Burden-Teh, Jane Ravenscroft
Managing acne vulgaris: an update. Drug and therapeutics bulletin 62 (1) (2023)
Miriam Santer, Esther Burden-Teh, Jane Ravenscroft
Managing acne vulgaris: an update. Drug and therapeutics bulletin 62 (1) (2023)
Miriam Santer, Esther Burden-Teh, Jane Ravenscroft
Managing acne vulgaris: an update. Drug and therapeutics bulletin 62 (1) (2023)
Miriam Santer, Esther Burden-Teh, Jane Ravenscroft
Managing acne vulgaris: an update. Drug and therapeutics bulletin 62 (1) (2023)
Miriam Santer, Esther Burden-Teh, Jane Ravenscroft
Managing acne vulgaris: an update. Drug and therapeutics bulletin 62 (1) (2023)

volume 61, number 7, 2023

David Erskine, John Minshull
Whither evidence? Drug and therapeutics bulletin 61 (7) (2023)
Dimitrios Karagkounis
Cardiac and renal effects of sodium-glucose co-transporter 2 inhibitors. Drug and therapeutics bulletin 61 (7) (2023)

volume 61, number 9, 2023

Delia Bishara
Managing drugs with anticholinergic activity. Drug and therapeutics bulletin 61 (9) (2023)